Free tool
Drug Trial Radar: Kidney and urology
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
3
Recruiting, industry sponsors, Kidney and urology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed133
3 trials
Showing 1 to 3, recently updated first.
Novo Nordisk A/SNovo Nordisk (NVO)
NCT07900438 · 300 participants (planned) · Start Oct 12, 2026 · Primary completion Dec 20, 2029
Drug: Semaglutide · For: Cardiovascular Risk; Chronic Kidney Disease
Sites: Fuyang, China; Beijing, China; Lanzhou, China · 26 sites in all
Ace Cells Lab LimitedIndustry
NCT07187713 · 300 participants (planned) · Start Sep 20, 2025 · Primary completion Aug 31, 2026
Drug: ACE Reno · For: Hypertensive Nephropathy; Auto Immune Disorders; Chronic Kidney Disease and 5 more
Sites: Giza, Egypt
Zydus Lifesciences LimitedIndustry
NCT05515367 · 1,004 participants (planned) · Start Apr 20, 2023 · Primary completion Jun 30, 2025
Drug: Desidustat · For: Chronic Kidney Diseases; Anemia of Chronic Kidney Disease
Sites: Sheikhpura, India
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.